AML, CHILDHOOD
Clinical trials for AML, CHILDHOOD explained in plain language.
Never miss a new study
Get alerted when new AML, CHILDHOOD trials appear
Sign up with your email to follow new studies for AML, CHILDHOOD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell therapy offers hope for Tough-to-Treat leukemia in young patients
Disease control Recruiting nowThis study is testing a new immune cell therapy for children and young adults (up to age 40) with high-risk acute myeloid leukemia (AML). The goal is to see if giving specially prepared 'memory-like' natural killer (NK) cells from a partially matched family donor is safe and poss…
Matched conditions: AML, CHILDHOOD
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for kids with tough blood cancers: experimental cell therapy trial opens
Disease control Recruiting nowThis study is testing a new type of CAR T-cell therapy for children and young adults (up to age 21) whose blood cancers have come back or haven't responded to standard treatments. The main goal of this early-phase trial is to find a safe and effective dose. Doctors will first giv…
Matched conditions: AML, CHILDHOOD
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC